| Literature DB >> 24035070 |
Meera Pahuja1, Ray W Shepherd2, Laurel J Lyckholm3.
Abstract
Octreotide, a synthetic analogue of the hormone somatostatin, is primarily used in palliative medicine because of its antisecretory effect and has been shown to be effective in the management of bowel obstruction, nausea, and diarrhea. Octreotide also has been successfully used for the management of bronchorrhea in both inpatient and outpatient settings. We report the case of a 47-year-old female with a history of bronchioloalveolar cell carcinoma whose copious bronchial secretions were controlled with octreotide. Octreotide should be further evaluated as a first-line treatment for bronchorrhea. Published by Elsevier Inc.Entities:
Keywords: Bronchorrhea; bronchioloalveolar carcinoma; octreotide
Mesh:
Substances:
Year: 2013 PMID: 24035070 PMCID: PMC4343310 DOI: 10.1016/j.jpainsymman.2013.06.008
Source DB: PubMed Journal: J Pain Symptom Manage ISSN: 0885-3924 Impact factor: 3.612